SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 373 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,000 | -87.5% | 11 | -88.9% | 0.00% | – |
| Q1 2022 | $8,000 | -11.1% | 99 | 0.0% | 0.00% | – |
| Q4 2021 | $9,000 | 0.0% | 99 | 0.0% | 0.00% | – |
| Q3 2021 | $9,000 | +12.5% | 99 | -4.8% | 0.00% | – |
| Q2 2021 | $8,000 | 0.0% | 104 | 0.0% | 0.00% | – |
| Q1 2021 | $8,000 | +300.0% | 104 | +1385.7% | 0.00% | – |
| Q4 2020 | $2,000 | -66.7% | 7 | -82.9% | 0.00% | – |
| Q3 2020 | $6,000 | -100.0% | 41 | -100.0% | 0.00% | -100.0% |
| Q2 2020 | $38,658,000 | +63.9% | 241,103 | +0.0% | 0.12% | +28.4% |
| Q1 2020 | $23,584,000 | -24.2% | 241,096 | 0.0% | 0.10% | -5.9% |
| Q4 2019 | $31,111,000 | -6.4% | 241,096 | +10.3% | 0.10% | -9.8% |
| Q2 2019 | $33,223,000 | +474514.3% | 218,644 | +383486.0% | 0.11% | – |
| Q1 2019 | $7,000 | -96.2% | 57 | -96.6% | 0.00% | -100.0% |
| Q4 2018 | $183,000 | +4475.0% | 1,666 | +7143.5% | 0.00% | – |
| Q3 2018 | $4,000 | -92.9% | 23 | -97.7% | 0.00% | – |
| Q4 2017 | $56,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |